secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001213900-23-065581
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics regains Nasdaq minimum bid price compliance after reverse stock split
--------------------------------------------------------------------------------

- Received Nasdaq notification on Aug 8, 2023 that minimum bid price deficiency is closed.
- Reverse stock split executed on July 24, 2023 to help regain compliance.
- Closing bid price was at least $1.00 for ten consecutive business days.
- Original deficiency was reported on October 25, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023065581/0001213900-23-065581-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390023065581/ea183294-8k_bluejaydia.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-065581

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer